Cardiovascular risk in chronic kidney disease (CKD): The CKD-mineral bone disorder (CKD-MBD)

Pediatric Nephrology

Volumn 25, Issue 4, 2010, Pages 769-778

  Hruska, Keith A ^a,b   Choi, Eric T ^a   Memon, Imran ^a   Davis, T Keefe ^a   Mathew, Suresh ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b Campus Box 8208 ^*  (United States)

Author keywords

Cardiovascular disease; Fetuin A; Matrix Gla protein; Phosphorus; Vascular calcifications; Vascular smooth muscle; Vitamin D

Indexed keywords

ALUMINUM; AUTACOID; BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; FETUIN; FIBROBLAST GROWTH FACTOR 23; INTERLEUKIN 6; INTERLEUKIN 8; IRON; LANTHANUM; LEPTIN; OSTEOCALCIN; PYROPHOSPHATE;

ALUMINUM BONE LEVEL; BLOOD VESSEL CALCIFICATION; BONE PAIN; CALCINOSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE MINERAL BONE DISEASE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; FRACTURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERPARATHYROIDISM; HYPERPHOSPHATEMIA; HYPERTENSION; HYPOCALCEMIA; HYPOGONADISM; METABOLIC ACIDOSIS; OSTEITIS FIBROSA; OSTEOMALACIA; OSTEOPOROSIS; OSTEOSCLEROSIS; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SKELETON MALFORMATION; TUMOR CALCINOSIS; VASCULAR SMOOTH MUSCLE; VITAMIN D DEFICIENCY;

ATHEROSCLEROSIS; CALCINOSIS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; HYPERPARATHYROIDISM, SECONDARY; HYPERPHOSPHATEMIA; KIDNEY FAILURE, CHRONIC; RENAL OSTEODYSTROPHY; RISK FACTORS;

EID: 77951253893     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-009-1337-0     Document Type: Conference Paper

References (67)

1. S Moe T Drueke J Cunningham W Goodman K Martin K Olgaard S Ott S Sprague N Lameire G Eknoyan 2006 Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 69 1945 1953 10.1038/sj.ki.5000414 1:STN:280:DC%2BD283ptl2nug%3D%3D 16641930 (Pubitemid 43924257)
2. LA Stevens O Djurdjev S Cardew EC Cameron A Levin 2004 Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: Evidence for the complexity of the association between mineral metabolism and outcomes J Am Soc Nephrol 15 770 779 10.1097/01.ASN.0000113243.24155.2F 1:CAS:528:DC%2BD2cXhtlShtbk%3D 14978180 (Pubitemid 38294808)
3. GA Block TE Hulbert-Shearon NW Levin FK Port 1998 Association of serum phosphorus and calcium X phosphate product with mortality risk in chronic hemodialysis patients: a national study Am J Kidney Dis 31 607 617 10.1053/ajkd.1998.v31.pm9531176 1:STN:280:DyaK1c7ovFKlsw%3D%3D 9531176 (Pubitemid 28158000)
4. MR Davies RJ Lund S Mathew KA Hruska 2005 Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome J Am Soc Nephrol 16 917 928 10.1681/ASN.2004100835 1:CAS:528:DC%2BD2MXjsVWqsbY%3D 15743994 (Pubitemid 41710302)
5. RJ Lund MR Davies AJ Brown KA Hruska 2004 Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model J Am Soc Nephrol 15 359 369 10.1097/01.ASN.0000109671.99498.08 1:CAS:528:DC%2BD2cXhtV2itbs%3D 14747382 (Pubitemid 38140776)
6. RN Foley PS Parfrey MJ Sarnak 1998 Clinical epidemiology of cardiovascular disease in chronic renal disease Am J Kidney Dis 32 S112 S119 10.1053/ajkd.1998.v32.pm9820470 1:STN:280:DyaK1M%2Fjs1emtA%3D%3D 9820470
7. Y Slinin RN Foley AJ Collins 2005 Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study J Am Soc Nephrol 16 1788 1793 10.1681/ASN.2004040275 1:CAS:528:DC%2BD2MXls1ehsr0%3D 15814832 (Pubitemid 41716485)
8. MG Shlipak MJ Sarnak R Katz LF Fried SL Seliger AB Newman DS Siscovick C Stehman-Breen 2005 Cystatin C and the risk of death and cardiovascular events among elderly persons New Engl J Med 352 2049 2060 10.1056/NEJMoa043161 1:CAS:528:DC%2BD2MXkt1Klsbk%3D 15901858 (Pubitemid 40664306)
9. RN Foley AJ Collins CA Herzog A Ishani PA Kalra 2009 Serum phosphorus levels associate with coronary atherosclerosis in young adults J Am Soc Nephrol 20 397 404 10.1681/ASN.2008020141 1:CAS:528:DC%2BD1MXjtFCrtLY%3D 18987306
10. HH Malluche MC Faugere 1990 Renal bone disease 1990: challenge for nephrologists Kidney Int 38 193 211 10.1038/ki.1990.187 1:STN:280: DyaK3czosVSrtw%3D%3D 2205749
11. J Bacchetta S Boutroy N Vilayphiou L Juillard F Guebre-Egziabher N Rognant E Sornay-Rendu P Szulc M Laville PD Delmas D Fouque R Chapurlat 2009 Early impairment of trabecular microarchitecture assessed with HR-pQCT in patients with stage II-IV chronic kidney disease J Bone Miner Res 0.1359/jbmr.090831 19775204
12. RC Pereira H Juppner CE Azucena-Serrano O Yadin IB Salusky K Wesseling-Perry 2009 Patterns of FGF-23, DMP1 and MEPE expression in patients with chronic kidney disease Bone 10.1016/j.bone.2009.08.008 19679205
13. T Kokubo N Ishikawa H Uchida SE Chasnoff X Xie S Mathew KA Hruska ET Choi 2009 CKD accelerates development of neointimal hyperplasia in arteriovenous fistulas J Am Soc Nephrol 20 1236 1245 10.1681/ASN.2007121312 1:CAS:528:DC%2BD1MXnvF2qsb4%3D 19423694
14. Fang Y, Zhang Y, Mathew S, Futhey J, Lund RJ, Hruska KA (2009) Early chronic kidney disease (CKD) stimulates vascular calcification (VD) and decreased bone formation rates prior to positive phosphate balance (abstract). J Am Soc Nephrol 20:36 A (abstract TH - FC 153)
15. LD Quarles 2003 FGF23, PHEX, and MEPE regulation of phosphate homeostasis and skeletal mineralization Am J Physiol Endocrinol Metab 285 1 9
16. T Shimada M Kakitani Y Yamazaki H Hasegawa Y Takeuchi T Fujita S Fukumoto K Tomizuka T Yamashita 2004 Targeted ablation of FGF23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism J Clin Invest 113 561 568 1:CAS:528:DC%2BD2cXhsFKhsbs%3D 14966565 (Pubitemid 38542505)
17. NK Lee H Sowa E Hinoi M Ferron JD Ahn C Confavreux R Dacquin PJ Mee MD McKee DY Jung Z Zhang JK Kim F Mauvais-Jarvis P Ducy G Karsenty 2007 Endocrine regulation of energy metabolism by the skeleton Cell 130 456 469 10.1016/j.cell.2007.05.047 1:CAS:528:DC%2BD2sXptlyntbs%3D 17693256 (Pubitemid 47208519)
18. Hruska KA, Mathew S (2008) The chronic kidney disease mineral bone disorder (CKD-MBD). In: Rosen CJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Am Soc Bone Miner Res, Washington D.C, pp 343-349
19. LM Calvi GB Adams KW Weibrecht JM Weber DP Olson MC Knight RP Martin E Schipani P Divieti FR Bringhurst LA Milner HM Kronenberg DT Scadden 2003 Osteoblastic cells regulate the haematopoietic stem cell niche Nature 425 841 846 10.1038/nature02040 1:CAS:528:DC%2BD3sXotlWqsbs%3D 14574413 (Pubitemid 37351468)
20. J Zhang C Niu L Ye H Huang XI He W-G Tong J Ross J Haug T Johnson JQ Feng S Harris LM Wiedemann Y Mishina L Li 2003 Identification of the haematopoietic stem cell niche and control of the niche size Nature 425 836 841 10.1038/nature02041 1:CAS:528:DC%2BD3sXotlWqsbg%3D 14574412 (Pubitemid 37351467)
21. HH Malluche E Ritz HP Lange 1976 Bone histology in incipient and advanced renal failure Kidney Int 9 355 362 10.1038/ki.1976.42 1:STN:280: DyaE283ktFCltw%3D%3D 940274
22. T Larsson U Nisbeth O Ljunggren H Juppner KB Jonsson 2003 Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers Kidney Int 64 2272 2279 10.1046/j.1523-1755.2003.00328.x 1:CAS:528:DC%2BD3sXpvFOqtLw%3D 14633152 (Pubitemid 37449564)
23. L Craver MP Marco I Martinez M Rue M Borras ML Martin F Sarro JM Valdivielso E Fernandez 2007 Mineral metabolism parameters throughout chronic kidney disease stages 1-5-achievement of K/DOQI target ranges Nephrol Dial Transplant 22 1171 1176 10.1093/ndt/gfl718 1:CAS:528:DC%2BD2sXjslOgtLc%3D 17205962 (Pubitemid 46523434)
24. A Levin GL Bakris M Molitch M Smulders J Tian LA Williams DL Andress 2006 Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease Kidney Int 71 31 38 10.1038/sj.ki.5002009 17091124 (Pubitemid 44967731)
25. 3 in smooth muscle cell migration to osteopontin in vitro J Clin Invest 95 713 724 10.1172/JCI117718 1:CAS:528:DyaK2MXjsV2rs70%3D 7532190
26. NX Chen KD O'Neill D Duan SM Moe 2002 Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells Kidney Int 62 1724 1731 10.1046/j.1523-1755.2002.00625.x 1:CAS:528:DC%2BD38Xos1ekt70%3D 12371973 (Pubitemid 35286280)
27. X Li HY Yang CM Giachelli 2008 BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells Atherosclerosis 199 271 277 10.1016/j.atherosclerosis.2007.11.031 1:CAS:528:DC%2BD1cXptVWksbs%3D 18179800
28. The ADHR consortium (Group 1: White KE, Evans WE, O'Riordan JLH, Speer MC, Econs JJ, Groups 2: Lorenz-Depiereux B, Grabowski M, Meitinger T, Strom TM) (2000) Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23. Nat Genet 26:345-348
29. KE White KB Jonsson G Carn G Hampson TD Spector M Mannstadt B Lorenz-Depiereux A Miyauchi IM Yang O Ljunggren T Meitinger TM Strom H Juppner MJ Econs 2001 The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting J Clin Endocrinol Metab 86 497 500 10.1210/jc.86.2.497 1:CAS:528:DC%2BD3MXht1Kns70%3D 11157998 (Pubitemid 32207449)
30. T Shimada T Muto I Urakawa T Yoneya Y Yamazaki K Okawa Y Takeuchi T Fujita S Fukumoto T Yamashita 2002 Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo Endocrinology 143 3179 3182 10.1210/en.143.8. 3179 1:CAS:528:DC%2BD38Xls1Sgtbs%3D 12130585 (Pubitemid 34809892)
31. WG Goodman LD Quarles 2007 Development and progression of secondary hyperparathyroidism in chronic kidney disease: Lessons from molecular genetics Kidney Int 74 276 288 10.1038/sj.ki.5002287 17568787
32. T Naveh-Many R Marx E Keshet JW Pike J Silver 1990 Regulation of 1, 25-dihydroxyvitamin D3 receptor gene expression by 1, 25-dihydroxyvitamin D3 in the parathyroid in vivo J Clin Invest 86 1968 1975 10.1172/JCI114931 1:CAS:528:DyaK3MXhvVSksw%3D%3D 2174913 (Pubitemid 20326255)
33. J Silver J Russell LM Sherwood 1985 Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells Proc Natl Acad Sci USA 82 4270 4273 10.1073/pnas.82.12.4270 1:CAS:528:DyaL2MXksVymu7k%3D 3858880 (Pubitemid 15053625)
34. JR Wu-Wong W Noonan J Ma D Dixon M Nakane AL Bolin KA Koch S Postl SJ Morgan GA Reinhart 2006 Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification J Pharmacol Exp Ther 318 90 98 10.1124/jpet.106.101261 1:CAS:528:DC%2BD28XmsFymsLc%3D 16603671 (Pubitemid 43920745)
35. M Mizobuchi JL Finch DR Martin E Slatopolsky 2007 Differential effects of vitamin D receptor activators on vascular calcification in uremic rats Kidney Int 72 709 715 10.1038/sj.ki.5002406 1:CAS:528:DC%2BD2sXpvFWlsb8%3D 17597697 (Pubitemid 47373790)
36. S Mathew RJ Lund LR Chaudhary T Geurs KA Hruska 2008 Vitamin D receptor activators can protect against vascular calcification J Am Soc Nephrol 19 1509 1519 10.1681/ASN.2007080902 1:CAS:528:DC%2BD1cXhtVWltr3P 18448587
37. Mathew S, Strebeck F, Hruska KA (2007) Vascular calcification (VC) protective actions of doxercalciferol in CKD. In: Gendreau MA, Mangili A, Zavod A (eds) Vitamin D therapy in dialysis patients: impact on survival and vascular calcification. Millennium CME Institute, Hampton
38. E Slatopolsky AM Robson I Elkan NS Bricker 1968 Control of phosphate excretion in uremic man J Clin Invest 47 1865 1874 1:CAS:528:DyaF1cXkslGisLY%3D 5666116
39. P Kurz M-C Monier-Faugere B Bognar E Werner P Roth J Vlachojannis HH Malluche 1994 Evidence for abnormal calcium homeostasis in patients with adynamic bone disease Kidney Int 46 855 861 10.1038/ki.1994.342 1:STN:280:DyaK2M%2FovFejtg%3D%3D 7996807 (Pubitemid 24272045)
40. E Moallem R Kilav J Silver T Naveh-Many 1998 RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate J Biol Chem 273 5253 5259 10.1074/jbc.273.9.5253 1:CAS:528:DyaK1cXhs1Cnsrk%3D 9478982 (Pubitemid 28108690)
41. T Naveh-Many R Rahamimov N Livni J Silver 1995 Parathyroid cell proliferation in normal and chronic renal failure rats J Clin Invest 96 1786 1793 10.1172/JCI118224 1:CAS:528:DyaK2MXosFyhtr4%3D 7560070
42. S Jono MD McKee CE Murry A Shioi Y Nishizawa K Mori H Morii CM Giachelli 2000 Phosphate regulation of vascular smooth muscle cell calcification Circ Res 87 e10 e17 1:CAS:528:DC%2BD3MXhslOisbs%3D 11009570
43. X Li HY Yang CM Giachelli 2006 Role of the sodium-dependent phosphate cotransporter, Pit-1, in Vascular Smooth Muscle Cell Calcification Circ Res 98 905 912 10.1161/01.RES.0000216409.20863.e7 1:CAS:528:DC%2BD28Xjt1Cls7g%3D 16527991 (Pubitemid 43755243)
44. EM Brown G Gamba D Riccardi M Lombardi R Butters O Kifor A Sun MA Hediger J Lytton SC Hebert 1993 Cloning and characterization of an extracellular Ca2 + -sensing receptor from bovine parathyroid Nature 366 575 580 10.1038/366575a0 1:CAS:528:DyaK2cXhvVGmtLs%3D 8255296 (Pubitemid 24035999)
45. 2+ on renal function? J Am Soc Nephrol 6 1530 1540 1:CAS:528:DyaK28XhtVOmsbs%3D 8749677 (Pubitemid 26184574)
46. MC Langub Jr NJ Koszewski HV Turner MC Monier-Faugere Z Geng HH Malluche 1996 Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy Kidney Int 50 515 520 10.1038/ki.1996.343 8840280 (Pubitemid 26274379)
47. P Stenvinkel P Barany O Heimburger R Pecoits-Filho B Lindholm 2002 Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int 61 S103 S108 10.1046/j.1523-1755.61.s80.19.x
48. EM Simmons J Himmelfarb MT Sezer GM Chertow RL Mehta EP Paganini S Soroko S Freedman K Becker D Spratt Y Shyr TA Ikizler 2004 Plasma cytokine levels predict mortality in patients with acute renal failure Kidney Int 65 1357 1365 10.1111/j.1523-1755.2004.00512.x 1:CAS:528:DC%2BD2cXjtFyqu7c%3D 15086475 (Pubitemid 38406974)
49. R Pecoits-Filho P Barany B Lindholm O Heimburger P Stenvinkel 2002 Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment Nephrol Dial Transplant 17 1684 1688 10.1093/ndt/17.9.1684 1:CAS:528:DC%2BD38Xms1Klu78%3D 12198224 (Pubitemid 35012175)
50. Hruska KA (1998) Growth factors and cytokines in renal osteodystrophy. In: Bushinsky DA (ed) Renal osteodystrophy. Lippincott-Raven, Philadelphia, pp 221-261
51. DA Bushinsky 1995 The contribution of acidosis to renal osteodystrophy Kidney Int 47 1816 1832 10.1038/ki.1995.251 1:STN:280:DyaK2MzntFaqsg%3D%3D 7643553
52. NS Krieger NE Sessler DA Bushinsky 1992 Acidosis inhibits osteoblastic and stimulates osteoclastic activity in vitro Am J Physiol 262 F442 F448 1:CAS:528:DyaK38XisFemsb8%3D 1558161
53. AM Alem DJ Sherrard DL Gillen NS Weiss SA Beresford SR Heckbert C Wong C Stehman-Breen 2000 Increased risk of hip fracture among patients with end-stage renal disease Kidney Int 58 396 399 10.1046/j.1523-1755.2000.00178.x 1:STN:280:DC%2BD3cvgs1Sitw%3D%3D 10886587 (Pubitemid 30429887)
54. J Cunningham S Sprague J Cannata-Andia M Coco M Cohen-Solal L Fitzpatrick D Goltzmann MH Lafage-Proust M Leonard S Ott M Rodriguez C Stehman-Breen P Stern J Weisinger 2004 Osteoporosis in chronic kidney disease Am J Kidney Dis 43 566 571 10.1053/j.ajkd.2003.12.004 14981616 (Pubitemid 38298217)
55. C Stehman-Breen 2004 Osteoporosis and chronic kidney disease Semin Nephrol 24 78 81 10.1053/j.semnephrol.2003.08.013 14730513 (Pubitemid 38141848)
56. M Rix H Andreassen P Eskildsen B Langdahl K Olgaard 1999 Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure Kidney Int 56 1084 1093 10.1046/j.1523-1755.1999.00617.x 1:STN:280:DyaK1MzpvVGguw%3D%3D 10469378 (Pubitemid 29411737)
57. M Bonyadi SD Waldman D Liu JE Aubin MD Grynpas WL Stanford 2003 Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice Proc Natl Acad Sci USA 100 5840 5845 10.1073/pnas.1036475100 1:CAS:528:DC%2BD3sXjvFOlsLY%3D 12732718 (Pubitemid 36576895)
58. C Stehman-Breen 2001 Bone mineral density measurements in dialysis patients Semin Dial 14 228 229 10.1046/j.1525-139X.2001.00057-2.x 1:STN:280:DC%2BD3MzmtlWkug%3D%3D 11422932
59. C Stehman-Breen D Sherrard A Walker R Sadler A Alem J Lindberg 1999 Racial differences in bone mineral density and bone loss among end-stage renal disease patients Am J Kidney Dis 33 941 946 10.1016/S0272-6386(99)70430-0 1:STN:280:DyaK1M3jtVWltQ%3D%3D 10213653 (Pubitemid 29214694)
60. M Coco H Rush 2000 Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone Am J Kidney Dis 36 1115 1121 10.1053/ajkd.2000.19812 1:STN:280:DC%2BD3M%2FnslWrtA%3D%3D 11096034
61. KA Hruska G Saab S Mathew R Lund 2007 Renal osteodystrophy, phosphate homeostasis, and vascular calcification Semin Dial 20 309 315 10.1111/j.1525-139X.2007.00300.x 17635820
62. S Khosla D Burr J Cauley DW Dempster PR Ebeling D Felsenberg RF Gagel V Gilsanz T Guise S Koka LK McCauley J McGowan MD McKee S Mohla DG Pendrys LG Raisz SL Ruggiero 2007 Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American society for bone and mineral research J Bone Miner Res 22 1479 1491 10.1359/jbmr.0707onj 17663640 (Pubitemid 351229318)
63. S Ichikawa EA Imel ML Kreiter X Yu DS Mackenzie AH Sorenson R Goetz M Mohammadi KE White MJ Econs 2007 A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis J Clin Invest 117 2684 2691 10.1172/JCI31330 1:CAS:528:DC%2BD2sXhtVCms7nJ 17710231 (Pubitemid 47494368)
64. S Ichikawa KW Lyles MJ Econs 2005 A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: Evidence that the disorder is autosomal recessive J Clin Endocrinol Metab 90 2420 2423 10.1210/jc.2004-2302 1:CAS:528:DC%2BD2MXjsFWis7s%3D 15687324 (Pubitemid 40590063)
65. A Benet-Pages P Orlik TM Strom B Lorenz-Depiereux 2005 An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia Hum Mol Genet 14 385 390 10.1093/hmg/ddi034 1:CAS:528:DC%2BD2MXkt1Wktw%3D%3D 15590700 (Pubitemid 40220655)
66. SC Schiavi R Kumar 2004 The phosphatonin pathway: New insights in phosphate homeostasis Kidney Int 65 1 14 10.1111/j.1523-1755.2004.00355.x 1:CAS:528:DC%2BD2cXmt1SqsQ%3D%3D 14675031 (Pubitemid 38037486)
67. H Kurosu Y Ogawa M Miyoshi M Yamamoto A Nandi KP Rosenblatt MG Baum S Schiavi MC Hu OW Moe M Kuro-o 2006 Regulation of fibroblast growth factor-23 signaling by Klotho J Biol Chem 281 6120 6123 10.1074/jbc.C500457200 1:CAS:528:DC%2BD28XhvFOhtLk%3D 16436388 (Pubitemid 43847540)